Oxaloacetate Treatment For Mental And Physical Fatigue In Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long-COVID fatigue patients: a non-randomized controlled clinical trial

BACKGROUND: There is no approved pharmaceutical intervention for Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome (ME/CFS). Fatigue in these patients can last for decades. Long COVID may continue to ME/CFS, and currently, it is estimated that up to 20 million Americans have significant symptoms a...

Descripción completa

Detalles Bibliográficos
Autores principales: Cash, Alan, Kaufman, David Lyons
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238249/
https://www.ncbi.nlm.nih.gov/pubmed/35764955
http://dx.doi.org/10.1186/s12967-022-03488-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238249/
https://www.ncbi.nlm.nih.gov/pubmed/35764955
http://dx.doi.org/10.1186/s12967-022-03488-3

Ejemplares similares